6+ hour, 39+ min ago   (574+ words) D&D Pharmatechs’ zabopegdutide shows rapid, weight-loss-independent MASH benefit Clinical Trials Arena D&D Pharmaceuticals, a South Korean clinical-stage biopharmaceutical company focused on developing medicines for metabolic, fibrotic, and neurodegenerative diseases, has recently published new data from its ongoing Phase…...

4+ hour, 42+ min ago   (455+ words) Clinical Trials Arena As populations age, the number of people living with mild cognitive impairment (MCI) and Alzheimer’s disease is expected to increase substantially, placing pressure on healthcare systems worldwide. MCI is often considered the transitional stage between normal ageing and…...

11+ hour, 46+ min ago   (324+ words) Estrella Immunopharma has dosed the first patient in the dose-expansion segment of its STARLIGHT-1 Phase I/II trial underway, assessing EB103 for relapsed or refractory (r/r) B-cell non-Hodgkin’s lymphoma (NHL). EB103 is a Cluster of Differentiation 19 (CD19)-redirected ARTEMIS T-cell therapy. The move…...

10+ hour, 23+ min ago   (419+ words) The trial included data from 813 adults and children aged two years and older with moderate to severe atopic dermatitis. Organon has reported findings from a post hoc analysis of pooled data from its Phase III ADORING 1 and ADORING 2 pivotal trials…...

3+ day, 10+ hour ago   (323+ words) The study enrolled at least 75 patients across 25 clinical sites in 13 countries. A part of the company’s NAVIGATE programme, the trial aims to assess the effects of nizubaglustat, an orally administered small molecule, on neurological manifestations and disease progression in these…...

3+ day, 12+ hour ago   (294+ words) The Phase I trial aims to determine maximum tolerated dose, evaluate pharmacokinetics, and gather preliminary efficacy data. Bio-Thera Solutions has initiated dosing in a Phase I clinical trial of BAT8013, an antibody drug conjugate (ADC) designed to target cluster of differentiation…...

3+ day, 6+ hour ago   (323+ words) China’s rapid rise in drug development casts a long shadow over US oncology Clinical Trials Arena 2026 marks a clear turning point for China’s position in the global clinical trials arena, particularly in oncology. At this year’s American Society of Clinical…...

3+ day, 8+ hour ago   (376+ words) The study enrolled 1,101 children with pneumonia who were randomised to receive either oral or injectable antibiotics after an injectable run-in. Children hospitalised with severe pneumonia can safely switch from injectable to oral antibiotics once they begin to recover, a clinical…...

3+ day, 12+ hour ago   (1366+ words) Operation Trialblazer is expected to shape early-stage planning, but experts debate its long term impact. With Operation Trialblazer set to expedite early-stage research in the US, experts anticipate that the fast-tracked investigational new drug (IND) stage could be a significant…...

3+ day, 10+ hour ago   (519+ words) The MonumenTAL-6 results add to the growing body of evidence touting Talvey and Tecvayli’s use in earlier multiple myeloma treatment lines. Johnson & Johnson (J&J) has posted a duo of Phase III wins for two of its budding multiple myeloma combination…...